Poorer people are being prescribed more expensive branded drugs. Is that bad? According to a new investigation it is. And it is costing the taxpayers a shovel-load of money. Furthermore, it’s unnecessary.
MB Donahue
Advertisement
Articles by MB Donahue
Advertisement
Latest Updated Articles
- Medicare “Wasting Billions of Dollars”, Says Study
Published: November 21st 2013 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Organon CEO Kevin Ali to Resign Following Internal Investigation into Nexplanon Sales
2
Study Claims Ozempic Lowers Biological Age
3
Pharmaceutical Executive Daily: Organon CEO Kevin Ali Resigns
4
How will DTC Programs Impact PBMs?
5
